Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 15:28:100526.
doi: 10.1016/j.ijcha.2020.100526. eCollection 2020 Jun.

Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study

Affiliations

Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study

Mohaned Egred et al. Int J Cardiol Heart Vasc. .

Abstract

Background: The aim of this clinical research was to investigate the effects of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size at 5 days after primary percutaneous coronary intervention (pPCI) in patients with ST-segment elevation myocardial infarction (STEMI).

Methods and results: This comparative study was carried out in four UK hospitals. Forty-five patients with anterior STEMI presenting within 12 h of symptom onset received pPCI plus PiCSO (initiated after reperfusion; n = 45) and were compared with a propensity score-matched control cohort from INFUSE-AMI (n = 80). Infarct size (% of LV mass, median [interquartile range]) measured by cardiac magnetic resonance (CMR) at day 5 was significantly lower in the PiCSO group (14.3% [95% CI 9.2-19.4%] vs. 21.2% [95% CI 18.0-24.4%]; p = 0.023). There were no major adverse cardiac events (MACE) related to the PiCSO intervention.

Conclusions: PiCSO, as an adjunct to pPCI, was associated with a lower infarct size at 5 days after anterior STEMI in a propensity score-matched population.

Keywords: ACS, acute coronary syndrome; AMI, acute myocardial infarction; BARC, Bleeding Academic Research Consortium; CI, Confidence interval; CMR, Cardiac magnetic resonance; CRT, Cardiac Resynchronization Therapy; IMR, Index of microcirculatory resistance; Infarct size reduction; LAD, left anterior descending artery; LV, Left ventricle; MACE, Major adverse cardiac events; PiCSO, Pressure-controlled intermittent coronary sinus occlusion; Pressure-controlled intermittent coronary sinus occlusion (PICSO); SD, Standard deviation; ST-segment elevation myocardial infarction (STEMI); STEMI, ST-segment elevation myocardial infarction; TIMI, Thrombosis in myocardial infarction; pPCI, Primary percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following conflicts of interests:•Mohaned Egred reports no relationships that could be construed as a conflict of interest•Alan Bagnall reports no relationships that could be construed as a conflict of interest•Ioakim Spyridopoulos reports no relationships that could be construed as a conflict of interest•Ian F. Purcell reports no relationships that could be construed as a conflict of interest•Rajiv Das reports no relationships that could be construed as a conflict of interest•Nick Palmer reports no relationships that could be construed as a conflict of interest•Ever D. Grech reports no relationships that could be construed as a conflict of interest•Ajay Jain reports no relationships that could be construed as a conflict of interest•Gregg W. Stone has received consulting fees from Miracor.•Robin Nijveldt reports no relationships that could be construed as a conflict of interest•Thomas McAndrew reports no relationships that could be construed as a conflict of interest•Azfar Zaman has received consulting fees from Miracor.

Figures

Fig. 1
Fig. 1
Study flow diagram. CMR: cardiac magnetic resonance imaging; PiCSO: Pressure-controlled intermittent Coronary Sinus Occlusion; pPCI: primary percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction.
Fig. 2
Fig. 2
Infarct size in propensity score-matched PiCSO and control patients with STEMI who underwent pPCI. Error bars show 95% confidence intervals. PiCSO: Pressure-controlled intermittent Coronary Sinus Occlusion; pPCI: primary percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction.

References

    1. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019;40(2):87–165. - PubMed
    1. Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 2018;39(2):119–177. - PubMed
    1. Puymirat E., Simon T., Steg P.G., Schiele F., Gueret P., Blanchard D. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308(10):998–1006. - PubMed
    1. Doost Hosseiny A., Moloi S., Chandrasekhar J., Farshid A. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart. 2016;3(1) - PMC - PubMed
    1. Stone G.W., Selker H.P., Thiele H., Patel M.R., Udelson J.E., Ohman E.M. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. J. Am. Coll. Cardiol. 2016;67(14):1674–1683. - PubMed